Black Diamond Therapeutics BDTX 深 滬
已收盤 05-08 16:00:00 美东时间
2.99
+0.270
+9.93%
華盛通- 最 高3.15
- 今 開2.72
- 成交量 166.33万股
- 最 低 2.70
- 昨 收 2.72
- 總市值 1.71亿
- 52周最高 4.94
- 市盈率 靜 7.69
- 換手率 2.90%
- 52周最低 1.9041
- 委 比 -62.49%
- 總股本 5730.18万
- 歷史最高 46.25
- 量 比 1.55
- 振 幅 16.54%
- 歷史最低 1.18
- 每 手 1
- 風險率 0.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Black Diamond Group renews share buyback program
Black Diamond Group (BDIMF) said on Friday the Toronto Stock Exchange approved the renewal of its normal course issuer bid, allowing the company to repurchase up to 5.26M common shares beginning May 1...
05-08 20:10
Black Diamond Therapeutic Q1 EPS $(0.16) Misses $(0.03) Estimate
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.03) by 433.33 percent. This is a 116.33 percent decrease over earnings of $0.98
05-07 21:34
Black Diamond (BDI) Signals Growth Despite EPS Drag
Black Diamond (BDI) (($TSE:BDI)) has held its Q1 earnings call. Read on for the...
05-05 08:20
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
BTIG Maintains Buy on Black Diamond Therapeutic, Raises Price Target to $11
BTIG analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the price target from $10 to $11.
04-29 18:38
SS&C Technologies Hldgs Reports Q1 2026 Results: Full Earnings Call Transcript
SS&C Technologies Hldgs (NASDAQ:SSNC) held its first-quarter earnings confe...
04-24 06:01
Lodestar Metals signs lease-to-buy Black Diamond mining patent for USD 75,000
Lodestar Metals signs lease-to-buy Black Diamond mining patent for USD 75,000 Lodestar Metals entered a lease-and-purchase agreement to acquire Black Diamond mining patent at its Gold Run project in Nevada. Deal calls for total cash payments of USD 75,000, split into USD 20,000 on signing, USD 20,00
04-16 19:36
美股大行评级 | 摩根大通上调哔哩哔哩至"超配"，目标价从27美元升至35美元；Rhythm遭花旗、大摩等多家机构下调目标价
今日重点评级关注：韦德布什：维持Black Diamond Therapeutic"跑赢大市"评级，目标价从13美元升至14美元；花旗：维持Olema Pharmaceuticals"买入"评级，目标价从60美元升至62美元
03-18 10:48
Black Diamond Therapeutic Q4 EPS $(0.27) Misses $(0.19) Estimate
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.19) by 41.36 percent. This is a 3.57 percent increase over losses of $(0.28) per
03-17 04:04
